We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ReflectionBio

News List

Patient-Driven Gene Therapy Company ReflectionBio Receives Orphan Drug Designation From U.S. FDA For the Treatment of Bietti's Crystalline Dystrophy (BCD) pharmafocusasia
November 26, 2018
Reflection Biotechnologies Limited ("ReflectionBio"), a gene therapy company committed to the research and development...
ReflectionBio Receives Orphan Drug Designation from FDA americanpharmaceuticalreview
August 29, 2018
Reflection Biotechnologies Limited (ReflectionBio) announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ReflectionBio's RBIO-101 program (AAV.CYP4V2), an AAV-based gene therapy product for treating Bietti's Crystall